Search research articles
Contact Us
Filters
Showing results (31-40 of 112) with videos related to
Page
of 12
Sort By:
Oncology Reports
|
November 16, 2012
Antiproliferative effects of kisspeptin‑10 depend on artificial GPR54 (KISS1R) expression levels
Elke Ziegler, Teresa Olbrich, Günter Emons, et al.
Cancer Research
|
February 20, 2007
Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo
Stefanie Fister, Andreas R Günthert, Günter Emons, et al.
European Journal of Endocrinology
|
November 13, 2004
Gonadotropin-releasing hormone (GnRH) agonist triptorelin inhibits estradiol-induced serum response element (SRE) activation and c-fos expression in human endometrial, ovarian and breast cancer cells
Carsten Gründker, Andreas R Günthert, Martin Hellriegel, et al.
European Journal of Endocrinology
|
December 26, 2001
Biology of the gonadotropin-releasing hormone system in gynecological cancers
Carsten Gründker, Andreas R Günthert, Silke Westphalen, et al.
Biochemical and Biophysical Research Communications
|
June 11, 2002
Luteinizing hormone-releasing hormone induces JunD-DNA binding and extends cell cycle in human ovarian cancer cells
Andreas R Günthert, Carsten Gründker, Kirsten Hollmann, et al.
Geburtshilfe Und Frauenheilkunde
|
February 23, 2019
Mechanisms of Metastasis and Cell Mobility - The Role of Metabolism
Carsten Gründker, Matthias Läsche, Johanna W Hellinger, et al.
Anticancer Research
|
July 28, 2004
Luteinizing hormone-releasing hormone (LHRH) inhibits apoptosis induced by cytotoxic agent and UV-light but not apoptosis mediated through CD95 in human ovarian and endometrial cancer cells
Andreas R Günthert, Carsten Gründker, Bettina Böttcher, et al.
International Journal of Oncology
|
October 4, 2006
GnRH-II agonist [D-Lys6]GnRH-II inhibits the EGF-induced mitogenic signal transduction in human endometrial and ovarian cancer cells
Nicola Eicke, Andreas R Günthert, Günter Emons, et al.
Clinical Chemistry
|
August 27, 2002
Predictive value of routine circulating soluble endothelial cell adhesion molecule measurements during pregnancy
Thomas Krauss, Günter Emons, Walther Kuhn, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
October 2, 2012
Cell-free fetal DNA and adverse outcome in low risk pregnancies
Werner Stein, Sina Müller, Kai Gutensohn, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 112) with videos related to
Sort By:
Page
of 12
Oncology Reports
|
November 16, 2012
Antiproliferative effects of kisspeptin‑10 depend on artificial GPR54 (KISS1R) expression levels
Elke Ziegler, Teresa Olbrich, Günter Emons, et al.
Cancer Research
|
February 20, 2007
Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo
Stefanie Fister, Andreas R Günthert, Günter Emons, et al.
European Journal of Endocrinology
|
November 13, 2004
Gonadotropin-releasing hormone (GnRH) agonist triptorelin inhibits estradiol-induced serum response element (SRE) activation and c-fos expression in human endometrial, ovarian and breast cancer cells
Carsten Gründker, Andreas R Günthert, Martin Hellriegel, et al.
European Journal of Endocrinology
|
December 26, 2001
Biology of the gonadotropin-releasing hormone system in gynecological cancers
Carsten Gründker, Andreas R Günthert, Silke Westphalen, et al.
Biochemical and Biophysical Research Communications
|
June 11, 2002
Luteinizing hormone-releasing hormone induces JunD-DNA binding and extends cell cycle in human ovarian cancer cells
Andreas R Günthert, Carsten Gründker, Kirsten Hollmann, et al.
Geburtshilfe Und Frauenheilkunde
|
February 23, 2019
Mechanisms of Metastasis and Cell Mobility - The Role of Metabolism
Carsten Gründker, Matthias Läsche, Johanna W Hellinger, et al.
Anticancer Research
|
July 28, 2004
Luteinizing hormone-releasing hormone (LHRH) inhibits apoptosis induced by cytotoxic agent and UV-light but not apoptosis mediated through CD95 in human ovarian and endometrial cancer cells
Andreas R Günthert, Carsten Gründker, Bettina Böttcher, et al.
International Journal of Oncology
|
October 4, 2006
GnRH-II agonist [D-Lys6]GnRH-II inhibits the EGF-induced mitogenic signal transduction in human endometrial and ovarian cancer cells
Nicola Eicke, Andreas R Günthert, Günter Emons, et al.
Clinical Chemistry
|
August 27, 2002
Predictive value of routine circulating soluble endothelial cell adhesion molecule measurements during pregnancy
Thomas Krauss, Günter Emons, Walther Kuhn, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
October 2, 2012
Cell-free fetal DNA and adverse outcome in low risk pregnancies
Werner Stein, Sina Müller, Kai Gutensohn, et al.
Page
of 12